SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8571910
Source:
http://linkedlifedata.com/resource/pubmed/id/8571910
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0246249
,
umls-concept:C0520510
,
umls-concept:C1522609
,
umls-concept:C1554112
,
umls-concept:C1627358
,
umls-concept:C1801960
,
umls-concept:C1979874
,
umls-concept:C2349975
,
umls-concept:C2827155
pubmed:issue
1
pubmed:dateCreated
1996-3-1
pubmed:abstractText
The purpose of this study were to quantify abdominal vascular enhancement and to prove the feasibility of iron oxide-enhanced MR angiography in humans using three doses of superparamagnetic iron oxide agent AMI 227.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8571910-8751704
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7708173
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Contrast Media
,
http://linkedlifedata.com/resource/pubmed/chemical/Dextrans
,
http://linkedlifedata.com/resource/pubmed/chemical/Ferumoxytol
,
http://linkedlifedata.com/resource/pubmed/chemical/Iron
,
http://linkedlifedata.com/resource/pubmed/chemical/Magnetite Nanoparticles
,
http://linkedlifedata.com/resource/pubmed/chemical/Oxides
,
http://linkedlifedata.com/resource/pubmed/chemical/ferumoxides
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0361-803X
pubmed:author
pubmed-author:HahnP FPF
,
pubmed-author:KaufmanJ AJA
,
pubmed-author:Mayo-SmithW WWW
,
pubmed-author:SainoYY
,
pubmed-author:SharmaPP
,
pubmed-author:SlaterGG
pubmed:issnType
Print
pubmed:volume
166
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
73-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:8571910-Adult
,
pubmed-meshheading:8571910-Aged
,
pubmed-meshheading:8571910-Aorta
,
pubmed-meshheading:8571910-Contrast Media
,
pubmed-meshheading:8571910-Dextrans
,
pubmed-meshheading:8571910-Female
,
pubmed-meshheading:8571910-Ferumoxytol
,
pubmed-meshheading:8571910-Humans
,
pubmed-meshheading:8571910-Iron
,
pubmed-meshheading:8571910-Magnetic Resonance Angiography
,
pubmed-meshheading:8571910-Magnetite Nanoparticles
,
pubmed-meshheading:8571910-Male
,
pubmed-meshheading:8571910-Middle Aged
,
pubmed-meshheading:8571910-Muscles
,
pubmed-meshheading:8571910-Oxides
,
pubmed-meshheading:8571910-Portal Vein
,
pubmed-meshheading:8571910-Vena Cava, Inferior
pubmed:year
1996
pubmed:articleTitle
MR contrast material for vascular enhancement: value of superparamagnetic iron oxide.
pubmed:affiliation
Department of Radiology, Massachusetts General Hospital, Boston 02114, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II